Learn / BRVE
NASDAQ: BRVE
Braveheart Bio (BRVE) stock, explained like you're 5
Braveheart Bio trades on the Nasdaq under the ticker BRVE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- BRVE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Braveheart Bio a small, medium or large cap company?
No. Braveheart Bio is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Braveheart Bio makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BRVE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 67.8% in September (MarketBeat)
- BRVE,JNJ,PWP,AMKR,AGYS,ABTC | Stock Prices | Quote Comparison Yahoo Finance (Yahoo! Finance Canada)
- symbol__ Stock Quote Price and Forecast (CNN)
- A biotech company's management will join a live webcast Sept. 10 (Stock Titan)
- Heart drug developer Braveheart Bio surges on public debut after upsized IPO (Seeking Alpha)
Follow BRVE in your daily brief
Each trading day at 5 PM ET we post what happened to Braveheart Bio and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BRVE
Questions about Braveheart Bio stock
What does Braveheart Bio do?
Braveheart Bio trades on the Nasdaq under the ticker BRVE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Braveheart Bio?
Braveheart Bio trades under the ticker BRVE on the Nasdaq.
What is Braveheart Bio's market cap?
Braveheart Bio is a small cap stock with a market cap of about 1.8 billion dollars.
How does Braveheart Bio make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BRVE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BRVE stock every day?
Add BRVE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.